ENETS 2011 consensus guidelines for the management of patients with digestive neuroendocrine tumors: An update

Neuroendocrinology

Volumn 95, Issue 2, 2012, Pages 71-73

  Salazar, Ramon ^a   Wiedenmann, Bertram ^b   Rindi, Guido ^c   Ruszniewski, Philippe ^d  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c CATHOLIC UNIVERSITY   (Italy)

^d BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; DIGESTIVE SYSTEM TUMOR; HUMAN; MEDICAL SOCIETY; NEUROENDOCRINE TUMOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; NEUROENDOCRINE TUMORS;

EID: 84857839068     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000335600     Document Type: Review

References (14)

1. Wiedenmann B: From ENET to ENETS: A long odyssey in the land of small and rare tumors. Neuroendocrinology 2004; 80: 1-12.
2. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K, Reubi JC, Nilsson O, Delle Fave G, Ruszniewski P, Ahlman H, Wiedenmann B: Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394-424. (Pubitemid 40874886)
3. Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Valimaki M: Guidelines for the management gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). II. Specific NE tumour types. Acta Oncol 2004; 43: 626-636. (Pubitemid 39563935)
4. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54(suppl 4):iv1-iv16. (Pubitemid 40695259)
5. Rindi G, de Herder WW, O'Toole D, Wiedermann B: ENETS consensus guidelines for the management of digestive neuroendocrine tumors. Neuroendocrinology 2006; 84: 151-216.
6. Rindi G, de Herder WW, O'Toole D, Wiedenmann B: ENETS Consensus guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. Neuroendocrinology 2008; 87: 1-64.
7. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, et al: TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401. (Pubitemid 44451313)
8. Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, et al: TNM staging of midgut and hindgut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2007; 451: 757-762. (Pubitemid 47497934)
9. Rinke A, et al: Placebo-controlled, doubleblind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group. J Clin Oncol 2009; 27: 4656-4663.
10. Yao JC, et al: Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011; 364: 514-523.
11. Raymond E, et al: Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011; 364: 501-513.
12. Sobin L, Gospodarowicz M, Wittekind C: TNM Classification of Malignant Tumours. ed 7. Bognor Regis, Wiley-Blackwell, 2009.
13. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A: AJCC Cancer Staging Manual. New York, Springer, 2010.
14. Bosman F, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumours of the Digestive System. Lyon, IARC Press, 2010.